Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trialLoretta Fiorillo, Lisa M. Arkin, Rajneet K. Oberoi et al.|Journal of the American Academy of Dermatology|2024Cited by 28
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infectionAstrid Marchal, Elizabeth T. Cirulli, Iva Neveux et al.|Human Genetics and Genomics Advances|2024Cited by 6
Pediatric cutaneous Crohn disease: A case series of 89 patients and reviewGrace E. McKay, Bridget E. Shields, Lynn Liu et al.|Pediatric Dermatology|2024Cited by 6
Interleukin‐12/23 and Interleukin‐23 Inhibitors for the Treatment of Cutaneous Crohn's Disease: A Case Series From a Multi‐Institutional RegistryGrace E. McKay, Bridget E. Shields, Alexandra Coromilas et al.|JEADV Clinical Practice|2025Cited by 3